Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-anal Nifedipine as Add-on Therapy for Pain in Anal Fissure
2014-003351-65Phase 2Completed
- Sponsor
- RDD Pharma
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nifedipine in anal fissure, sponsored by RDD Pharma. Primary endpoint: Change in 24-hour average anal fissure rectal pain (VAS). Started Nov 2015; status: completed.
02
Drugs
nifedipine
03
Conditions
anal fissure
Beyond the preview
Go deeper on 2014-003351-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003351-65.